Pharmacological DNA demethylation: Implications for cancer immunotherapy

被引：25
作者：
Roulois, David [1 ]
Yau, Helen Loo [1 ,2 ]
De Carvalho, Daniel D. [1 ,2 ]
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
来源：
ONCOIMMUNOLOGY | 2016年 / 5卷 / 03期
基金：
加拿大自然科学与工程研究理事会;
关键词：
5-AZA-CdR; colorectal cancer; DNA methylation; decitabine; epigenetic therapy; CELLS;
D O I：
10.1080/2162402X.2015.1090077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recent studies have demonstrated that DNA demethylation agents can mimic a viral infection by induction of dsRNAs. This viral mimicry leads to an antiviral response mediated by the cytosolic pattern recognition receptor MDA5, followed by MAVS (IPS1) activation, IRF7 nuclear translocation and upregulation of type III Interferon and interferon-stimulated genes.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] DNA demethylation and cancer metastasis: therapeutic implications
    Szyf, Moshe
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (05) : 519 - 531
  • [2] DNA demethylation and cancer: therapeutic implications
    Szyf, M
    Pakneshan, P
    Rabbani, SA
    CANCER LETTERS, 2004, 211 (02) : 133 - 143
  • [3] TET Enzymes in the Immune System: From DNA Demethylation to Immunotherapy, Inflammation, and Cancer
    Lopez-Moyado, Isaac F.
    Ko, Myunggon
    Hogan, Patrick G.
    Rao, Anjana
    ANNUAL REVIEW OF IMMUNOLOGY, 2024, 42 : 455 - 488
  • [4] DNA demethylation triggers cell free DNA release in colorectal cancer cells
    Pessei, Valeria
    Macagno, Marco
    Mariella, Elisa
    Congiusta, Noemi
    Battaglieri, Vittorio
    Battuello, Paolo
    Viviani, Marco
    Gionfriddo, Giulia
    Lamba, Simona
    Lorenzato, Annalisa
    Oddo, Daniele
    Idrees, Fariha
    Cavaliere, Alessandro
    Bartolini, Alice
    Guarrera, Simonetta
    Linnebacher, Michael
    Monteonofrio, Laura
    Cardone, Luca
    Milella, Michele
    Bertotti, Andrea
    Soddu, Silvia
    Grassi, Elena
    Crisafulli, Giovanni
    Bardelli, Alberto
    Barault, Ludovic
    Di Nicolantonio, Federica
    GENOME MEDICINE, 2024, 16 (01):
  • [5] Epigenetic regulation of HERVs: Implications for cancer immunotherapy
    Yi, Joo Mi
    GENES & GENOMICS, 2024, 46 (11) : 1303 - 1312
  • [6] DNA repair defects and implications for immunotherapy
    Bever, Katherine M.
    Le, Dung T.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (10) : 4236 - 4242
  • [7] Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition
    Jakobsen, Mie K.
    Traynor, Sofie
    Nielsen, Aaraby Y.
    Dahl, Christina
    Staehr, Mette
    Jakobsen, Simon T.
    Madsen, Maria S.
    Siersbaek, Rasmus
    Terp, Mikkel G.
    Jensen, Josefine B.
    Pedersen, Christina B.
    Shrestha, Anup
    Brewer, Jonathan R.
    Duijf, Pascal H. G.
    Gammelgaard, Odd L.
    Ditzel, Henrik J.
    Kirkin, Alexei F.
    Guldberg, Per
    Gjerstorff, Morten F.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2025, 44 (01)
  • [8] Reactivation of Atp4a concomitant with intragenic DNA demethylation for cancer inhibition in a gastric cancer model
    Cao, Donghui
    Zhao, Dan
    Jia, Zhifang
    Su, Tongrong
    Zhang, Yangyu
    Wu, Yanhua
    Wu, Menghui
    Tsukamoto, Tetsuya
    Oshima, Masanobu
    Jiang, Jing
    Cao, Xueyuan
    LIFE SCIENCES, 2020, 242
  • [9] Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications
    Yin, Jun
    Gu, Tiezheng
    Chaudhry, Norin
    Davidson, Nancy E.
    Huang, Yi
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [10] The Microbiome and Its Implications in Cancer Immunotherapy
    Choudhry, Hani
    MOLECULES, 2021, 26 (01):
12345